GERMANY’s urban public transport operators expect to lose up to €3.5bn in revenue in 2021, even in the event a vaccine is developed by spring, a study from the Association of German Transport Companies (VDV) says.
Premium Subscription Required
You must be a premium subscriber to access this content:
Already a subscriber? Log in here
